Furthermore, the BRAF + PTEN mutant and BRAF/PTEN/NRAS wild-type cell lines were 2–3 fold more sensitive to BPH than to ZA (Figure S1B,D, Figure 1E). The gene discussed is NRAS; the disease is benign prostatic hyperplasia.